Showing results (1061-1070 of 1,160) with videos related to
Sort By:
Pageof 116
Human Mutation|January 22, 2008
Clinical and molecular features of mitochondrial DNA depletion due to mutations in deoxyguanosine kinaseD P Dimmock, Q Zhang, C Dionisi-Vici, et al.JAMA|October 26, 2018
Effect of Early Sustained Prophylactic Hypothermia on Neurologic Outcomes Among Patients With Severe Traumatic Brain Injury: The POLAR Randomized Clinical TrialD James Cooper, Alistair D Nichol, Michael Bailey, et al.Immunity|March 9, 2022
A nonredundant role for T cell-derived interleukin 22 in antibacterial defense of colonic cryptsCarlene L Zindl, Steven J Witte, Vincent A Laufer, et al.Breast Cancer Research and Treatment|April 13, 2023
Associations between health-related fitness and quality of life in newly diagnosed breast cancer patientsKerry S Courneya, Ki-Yong An, Fernanda Z Arthuso, et al.Annals of Surgery|April 11, 2025
Associations of Patient Age, Tumor Nephrectomy Weight, and Tumor Diameter with Event-Free and Overall Survival in Stage I or II Favorable Histology Wilms Tumor: A Pooled Analysis of Children's Oncology Group Studies AREN0532 and AREN03B2Lindsay A Renfro, Kelly L Vallance, Ian C Tfirn, et al.Journal of Critical Care|April 15, 2014
Heparin-induced thrombocytopenia in the critically ill: interpreting the 4Ts test in a randomized trialMark Crowther, Deborah Cook, Gordon Guyatt, et al.Med (New York, N.Y.)|October 4, 2022
Validation of a non-oncogene encoded vulnerability to exportin 1 inhibition in pediatric renal tumorsDiego F Coutinho, Prabhjot S Mundi, Lianna J Marks, et al.Biorxiv : the Preprint Server for Biology|June 19, 2024
Pathogenic diversification of the gut commensal <i>Providencia alcalifaciens</i> via acquisition of a second type III secretion systemJessica A Klein, Alexander V Predeus, Aimee R Greissl, et al.Infection and Immunity|September 10, 2024
Pathogenic diversification of the gut commensal <i>Providencia alcalifaciens</i> via acquisition of a second type III secretion systemJessica A Klein, Alexander V Predeus, Aimee R Greissl, et al.Ejhaem|May 1, 2025
Belantamab Mafodotin Monotherapy for Multiply-Relapsed Myeloma: A Retrospective Study From the United Kingdom and the Republic of IrelandEdmund C R Watson, Faouzi Djebbari, Fotios Panitsas, et al.Pageof 116